Skip to main content

and
  1. Article

    Open Access

    Latissimus dorsi musculocutaneous flap grafting to the infected recipient site in a patient with irradiated locally advanced breast cancer and multiple lung metastases

    Musculocutaneous (MC) flaps are more resistant to infection than implants, but no clinical results have been reported so far about the grafting of MC flap to the overtly infected sites.

    Yuki Ishii, Hitomi Matsuki, Nozomi Uozumi, Shoji Oura in Surgical Case Reports (2023)

  2. Article

    Open Access

    Evaluation of additional gastrectomy after noncurative endoscopic submucosal dissection for early gastric cancer

    Performing additional surgery after noncurative endoscopic submucosal dissection (ESD) for early gastric cancer is controversial. Our aims are to clarify the risk factors for lymph node metastasis (LNM) and lo...

    Shinichiro Makimoto, Yutaka Mushiake, Tomoya Takami, Hiroshi Shintani in BMC Surgery (2022)

  3. No Access

    Article

    Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration

    Upper-limb lymphedema is a well-known complication of breast cancer and its treatment. This retrospective cohort study aims to determine what risk factors affect breast cancer-related lymphedema in patients wi...

    Yuka Aoishi, Shoji Oura, Haruka Nishiguchi, Yoshimitsu Hirai in Breast Cancer (2020)

  4. No Access

    Article

    A case of bilateral methotrexate-associated diffuse large B-cell lymphomas of the breasts with unique clinical presentation and outcome

    A 54-year-old woman on methotrexate (MTX) treatment developed reddish skin change in her right breast. Mammography and ultrasound showed no masses in the breasts but bilateral mammary glands presented diffuse ...

    Masafumi Tomita, Shoji Oura, Haruka Nishiguchi, Shinichirou Makimoto in Breast Cancer (2020)

  5. No Access

    Article

    Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer

    Prognostic effects of circulating tumor cells (CTCs) have been reported in metastatic breast cancer (MBC). However, few phase III trials have investigated the potential role of CTCs in treatment selection. We ...

    Hiroji Iwata, Norikazu Masuda, Daigo Yamamoto in Breast Cancer Research and Treatment (2017)

  6. No Access

    Article

    Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial

    The randomized phase III JO21095 trial compared the efficacy and safety of low-dose capecitabine plus docetaxel combination therapy (XT) versus single-agent administration of docetaxel in anthracycline-pretrea...

    Daigo Yamamoto, Nobuaki Sato, Yoshiaki Rai in Breast Cancer Research and Treatment (2017)

  7. No Access

    Article

    Fibroadenoma of the axillary accessory breast: diagnostic value of dynamic magnetic resonance imaging

    Accessory breast is synonymous with polymastia or supernumerary breast tissue. An accessory breast without a nipple or areola is rare. We report a case of fibroadenoma of an accessory breast with no nipple or ...

    Munehisa Sawa, Nobuyuki Kawai, Morio Sato, Taizo Takeuchi in Japanese Journal of Radiology (2010)

  8. No Access

    Article

    Histoculture drug response assay for gefitinib in non-small-cell lung cancer

    There are many predictive factors for gefitinib sensitivity, including epidermal growth factor receptor (EGFR) gene mutation, EGFR copy number, and k-ras mutation. To investigate all of them is too expensive. We ...

    Tatsuya Yoshimasu, Fuminori Ohta, Shoji Oura in General Thoracic and Cardiovascular Surgery (2009)

  9. No Access

    Article

    In vitro evaluation of dose-response curve for paclitaxel in breast cancer

    The dose-response curve for anticancer agents cannot be evaluated by studying patients directly. To investigate individual differences in the dose-response curve for paclitaxel in breast cancer, we utilized th...

    Tatsuya Yoshimasu, Shoji Oura, Issei Hirai, Takeshi Tamaki, Yozo Kokawa in Breast Cancer (2007)

  10. No Access

    Article

    Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size

    Non-surgical ablation is an attractive approach as a local control method for breast cancer. The purpose of this study was to investigate the complications and efficacy of radiofrequency ablation (RFA) therapy...

    Shoji Oura, Takeshi Tamaki, Issei Hirai, Tatsuya Yoshimasu, Fuminori Ohta in Breast Cancer (2007)

  11. No Access

    Article

    A case of serum CEA disappearance curve after resection of breast carcinoma

    Carcinoembryonic antigen (CEA) elimination kinetics after tumor resection were measured in a case of breast cancer. A 45-year-old woman with a left breast carcinoma underwent surgery after neoadjuvant chemothe...

    Tatsuya Yoshimasu, Rie Sasaki, Shoji Oura, Issei Hirai, Yozo Kokawa in Breast Cancer (2004)

  12. No Access

    Article

    Clinical efficacy of bisphosphonate therapy for bone metastasis from breast cancer

    Bisphosphonates inhibit osteoclastic bone resorption and are being used as treatment for bone metastases from breast cancer. Intravenous bisphosphonate therapy can significantly reduce skeletal related events ...

    Shoji Oura, Issei Hirai, Tatsuya Yoshimasu, Yozo Kokawa, Rie Sasaki in Breast Cancer (2003)

  13. No Access

    Article

    MR-axillography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection

    We have reported that magnetic resonance axillography (MR-axillography) is the best method for assessing lymph node size and representing the relation of the lymph node to normal anatomy.

    Takaomi Suzuma, Takeo Sakurai, Goro Yoshimura, Teiji Umemura in Breast Cancer (2002)

  14. No Access

    Article

    Bisphosphonate therapy for bone metastases from Breast Cancer: Clinical results and a new therapeutic approach

    We evaluated the usefulness of bisphosphonate (BIS) monotherapy, the safety of rapid infusion of BIS and the efficacy of BIS-sequential therapy for bone metastases from breast cancer.

    Shoji Oura, Hirokazu Tanino, Tatsuya Yoshimasu, Teruhisa Sakurai in Breast Cancer (2000)